U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H28NO3.Br
Molecular Weight 398.335
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLYCOPYRROLATE

SMILES

[Br-].C[N+]1(C)CC[C@@H](C1)OC(=O)[C@@](O)(C2CCCC2)C3=CC=CC=C3

InChI

InChIKey=VPNYRYCIDCJBOM-QQTWVUFVSA-M
InChI=1S/C19H28NO3.BrH/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15;/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3;1H/q+1;/p-1/t17-,19-;/m0./s1

HIDE SMILES / InChI
Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C19H27NO3
Molecular Weight 317.4226
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:51:43 UTC 2023
Edited
by admin
on Fri Dec 15 15:51:43 UTC 2023
Record UNII
V92SO9WP2I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GLYCOPYRROLATE
MI   ORANGE BOOK   USAN   USP  
USAN  
Official Name English
GLYCOPYRROLATE [VANDF]
Common Name English
ULTIBRO COMPONENT GLYCOPYRRONIUM BROMIDE
Brand Name English
TARODYL
Brand Name English
NVA-237
Code English
GLYCOPYRROLATE COMPONENT OF BREZTRI
Brand Name English
CHF5259
Code English
PYRROLIDINIUM, 3-((CYCLOPENTYLHYDROXYPHENYLACETYL)OXY)-1,1-DIMETHYL-, BROMIDE
Systematic Name English
BREZTRI COMPONENT GLYCOPYRROLATE
Brand Name English
GLYCOPYRROLATE [ORANGE BOOK]
Common Name English
GLYCOPYRROLATE COMPONENT OF UTIBRON
Common Name English
PYRROLIDINIUM, 3-((2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETYL)OXY)-1,1-DIMETHYL-, BROMIDE (1:1)
Systematic Name English
PYRROLIDINIUM, 3-(((2R)-2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETYL)OXY)-1,1-DIMETHYL-, BROMIDE (1:1), (3S)-REL-
Systematic Name English
GLYCOPYRROLATE [USAN]
Common Name English
NSC-250836
Code English
SEEBRI
Brand Name English
NODAPTON
Brand Name English
PT-001
Code English
QVA149 COMPONENT GLYCOPYRRONIUM BROMIDE
Common Name English
ROBINUL
Brand Name English
TARODYN
Brand Name English
NSC-251252
Code English
LONHALA MAGNAIR KIT
Brand Name English
GLYCOPYRRONIUM BROMIDE [EP MONOGRAPH]
Common Name English
GLYRX-PF
Brand Name English
PREVDUO COMPONENT GLYCOPYRROLATE
Brand Name English
GLYCOPYRROLATE COMPONENT OF BEVESPI AEROSPHERE
Common Name English
GLYCOPYRRONIUM BROMIDE [JAN]
Common Name English
glycopyrronium bromide [INN]
Common Name English
GLYCOPYRRONIUM BROMIDE
EP   INN   JAN   MART.   WHO-DD  
INN  
Official Name English
CHF-5259
Code English
TRIMBOW COMPONENT GLYCOPYRRONIUM BROMIDE
Brand Name English
GLYCOPYRRONIUM BROMIDE [MART.]
Common Name English
ROBANUL
Brand Name English
QVA-149 COMPONENT GLYCOPYRRONIUM BROMIDE
Common Name English
NVA237
Code English
NSC-251251
Code English
GLYCOPYRROLATE, ERYTHRO-
Common Name English
BEVESPI AEROSPHERE COMPONENT GLYCOPYRROLATE
Brand Name English
PT001
Code English
3-HYDROXY-1,1-DIMETHYLPYRROLIDINIUM BROMIDE .ALPHA.-CYCLOPENTYLMANDELATE
Common Name English
GLYCOPYRRONIUM (AS BROMIDE)
Common Name English
GLYCOPYRROLATE COMPONENT OF PREVDUO
Brand Name English
AD-237
Code English
ORG-NC-45
Code English
BEVESPI AEROSPHERE COMPONENT OF GLYCOPYRROLATE
Common Name English
GLYCOPYRROLATE [GREEN BOOK]
Common Name English
GLYCOPYRROLATE [USP-RS]
Common Name English
GLYCOPYRROLATE [USP MONOGRAPH]
Common Name English
AHR-504
Code English
Glycopyrronium bromide [WHO-DD]
Common Name English
GLYCOPYRROLATE [MI]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 204105
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
EMA ASSESSMENT REPORTS SEEBRI BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
WHO-ATC R03AL04
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
EMA ASSESSMENT REPORTS ULUNAR BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
EMA ASSESSMENT REPORTS ULTIBRO BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
CFR 21 CFR 522.1066
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
WHO-ATC R03AL09
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
FDA ORPHAN DRUG 309810
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
WHO-ATC A03AB02
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
NDF-RT N0000175574
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
EMA ASSESSMENT REPORTS ENUREV BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
WHO-ATC A03CA05
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
NCI_THESAURUS C29704
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
WHO-ATC R03AL07
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
WHO-VATC QR03AL04
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
LIVERTOX NBK548229
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
WHO-ATC R03BB06
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
EMA ASSESSMENT REPORTS XOTERNA BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
EMA ASSESSMENT REPORTS TOVANOR BREEZHALER (AUTHORIZED: PULMONARY DISEASE, CHRONIC OBSTRUCTIVE)
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
WHO-VATC QR03BB06
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
Code System Code Type Description
RS_ITEM_NUM
1296009
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
MESH
D006024
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
IUPHAR
7459
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
NCI_THESAURUS
C29078
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
CHEBI
5494
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
CAS
596-51-0
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
ECHA (EC/EINECS)
209-887-0
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
MERCK INDEX
m5807
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY Merck Index
DAILYMED
V92SO9WP2I
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
CHEBI
90972
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
NSC
251251
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
DRUG CENTRAL
4302
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
NSC
250836
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
FDA UNII
V92SO9WP2I
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
CAS
59677-71-3
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
SUPERSEDED
SMS_ID
100000084232
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
NSC
251252
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
RXCUI
4955
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY RxNorm
DRUG BANK
DBSALT001183
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
INN
1038
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
PUBCHEM
67204829
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
LACTMED
Glycopyrrolate
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
EPA CompTox
DTXSID40199205
Created by admin on Fri Dec 15 15:51:44 UTC 2023 , Edited by admin on Fri Dec 15 15:51:44 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201335
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
EVMPD
SUB07951MIG
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
CAS
51186-83-5
Created by admin on Fri Dec 15 15:51:43 UTC 2023 , Edited by admin on Fri Dec 15 15:51:43 UTC 2023
PRIMARY
Related Record Type Details
MUSCARINIC ACETYLCHOLINE RECEPTOR M2
TARGET -> INHIBITOR
Ki
Structure of GLYCOPYRROLATE, (2S,3'R)-
ENANTIOMER -> RACEMATE
Structure of GLYCOPYRROLATE, (2R,3'S)-
ENANTIOMER -> RACEMATE
MUSCARINIC ACETYLCHOLINE RECEPTOR M3
TARGET -> INHIBITOR
Ki
MUSCARINIC ACETYLCHOLINE RECEPTOR M1
TARGET -> INHIBITOR
Ki
Structure of GLYCOPYRRONIUM
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of MANDELIC ACID
IMPURITY -> PARENT
Structure of CHLOROGLYCOPYRROLATE
IMPURITY -> PARENT
Structure of .ALPHA.-CYCLOPENTYLMANDELIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 1-METHYLPYRROLIDIN-3-YL 2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETATE HYDROCHLORIDE
IMPURITY -> PARENT
Structure of METHYL CYCLOPENTYLMANDELATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of CYCLOPENTYLPHENYLMETHANONE
IMPURITY -> PARENT
Structure of GLYCOPYRRONIUM ERYTHRO ISOMER
IMPURITY -> PARENT
USP
Structure of Benzoic acid
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of METHYL PHENYLGLYOXALATE
IMPURITY -> PARENT
Structure of BENZALDEHYDE
IMPURITY -> PARENT
Structure of METHYL .ALPHA.-CYCLOPENTYLIDENEBENZENEACETATE
IMPURITY -> PARENT
Structure of CYCLOPENTYLPHENYLACETIC ACID
IMPURITY -> PARENT
Structure of PHENYLGLYOXYLIC ACID
IMPURITY -> PARENT
Structure of 1-METHYLPYRROLIDIN-3-YL-2-CYCLOPENTYL-2-HYDROXY-2-PHENYLACETATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of 5-NITROISOPHTHALIC ACID
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
Structure of GLYCOPYRRONIUM
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966